Condition: Medulloblastoma · Sponsor: St. Jude Children's Research Hospital
This is a multi-center, multinational phase 2 trial that aims to explore the use of molecular and clinical risk-directed therapy in treatment of children 0-4.99 years of age with newly diagnosed medulloblastoma.
This description comes directly from the study's public registry record.
Tabatha E. Doyle, RN · 901-595-2544 · tabatha.doyle@stjude.org
Always discuss trial participation with your own doctor first.
| Lucille Packard Children's Hospital Stanford | Palo Alto, California, United States | Recruiting |
| Orlando Health Arnold Palmer Hospital for Children | Orlando, Florida, United States | Recruiting |
| St. Joseph's Children's Hospital | Tampa, Florida, United States | Recruiting |
| C.S. MOTT Children's Hospital, University of Michigan | Ann Arbor, Michigan, United States | Recruiting |
| Children's Hospital and Clinics of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| St. Jude Children's Research Hospital | Memphis, Tennessee, United States | Recruiting |
| UT Southwestern Medical Center/Harold C Simmons Comprehensive Cancer Center | Dallas, Texas, United States | Recruiting |
| Cook Children's Medical Center | Fort Worth, Texas, United States | Recruiting |
| Texas Children's Hospital | Houston, Texas, United States | Recruiting |
| Primary Children's Hospital | Salt Lake City, Utah, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05535166